The FDA has already authorized the Pfizer vaccine for use in children 12 to 15. Last December the FDA approved vaccination for those 16 and older. Vaccination in children 5-12 could start within weeks if the FDA authorizes the request by Pfizer/BioNTech. Pfizer expects data on vaccination in children ages 6 months to 5 years by Q4.
Infectious disease experts recommend vaccinating children. While they typically experience milder disease and are much less likely to die than adults, hospitals across the country reported more pediatric Covid-19 admissions than ever this summer. In addition, children are an important vector or carrier and transmitter of the virus to adults who are more likely to experience severe disease.
The vaccine 93% effective against hospitalization from Covid-19 in 12-18 year olds the CDC reported.
While symptoms in children are typically the same as adults, doctors are probing a link between a rare inflammatory condition that causes stomach pain, skin rashes, and high fever that begins following Covid-19 infection.
The risks of the vaccine in children is similar to adults. Most common side effects are fever, muscle aches, and chills. In extremely rare cases there have been severe allergic reactions to the vaccine including anaphylaxis. There appears to be an association between the mRNA vaccines and a rare inflammatory condition of the heart called myocarditis which tends to occur in young adults. Studies suggest that there aren’t safety risks for pregnant mothers or their unborn children from the vaccines.
CLICK HERE to read the Wall Street Journal Article.